Product
SHR0302 tablets
1 clinical trial
1 indication
Indication
Psoriatic ArthritisClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of SHR0302 in Active Psoriatic Arthritis SubjectsStatus: , Estimated PCD: 2024-11-13